Table 3.

Changes From Baseline in Insulin Sensitivity in the Completer Sample

Variable	Month	Testosterone (n = 56)	Placebo (n = 41)	P Value a
SSPG, mg/dL	3	−4.6 ± 4.9	−1.5 ± 5.8	0.68
	36	6.0 ± 6.1	15.6 ± 7.2	0.31
Weight, kg	36	0.39 ± 0.62	1.3 ± 0.41	0.23
BMI, kg/m2	36	0.12 ± 0.20	0.44 ± 0.15	0.20
Total lean mass, kg	36	1.3 ± 0.43	0.40 ± 0.41	0.14
Total fat mass, kg	36	1.3 ± 0.49	3.9 ± 0.46	<0.001

The completer sample included all participants who completed 36 months of study intervention. Data are presented as mean ± standard error.

^a P value for SSPG was derived from the mixed regression model; other P values were derived from the t test.